← Back to news

Markets

Michael Burry Says He 'Slept' on Bitcoin After Early 2013 Buying Opportunity

Y

The Best Stocks to Invest $50,000 in Right Now

Y

Is Cognex Stock a Buy or Sell After a Director Dumped Shares Worth $128,000?

Y

Counting on Home Equity to Fund Your Retirement? Here's Why You Shouldn't.

Y

Last week’s slump in asset-manager stocks was driven by private-credit fears. Here’s what’s worrying investors.

Y

'Seven Billionaires I Know Have Already Left' — Luxury Real Estate Broker Josh Altman Says California's 5% Wealth Tax Risks A 'Trickle-Down Effect'

Y

Retiring Next Year? Discover the Right Monthly Income Target

Y

TD Cowen Lifts PT on PepsiCo (PEP) to $165 From $162 – Here’s Why

Y

Why The Coca-Cola Company (KO) Is One of the Best Sugar Stocks to Buy According to Hedge Funds

Y

Where Will Rocket Lab Stock Be in 10 Years?

Y

Prediction: 3 Stocks That'll Be Worth More Than Walmart 5 Years From Now

Y

Novartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for Decades

Y

Boomers Are Retiring In Droves Each Year, Creating A Buying Opportunity In 'Boring' Businesses. But Which Ones Actually Make Sense?

Y

JFrog's CTO Sold Shares Worth $2.5 Million. Is the Stock a Buy or Sell?

Y

Is CrowdStrike Stock a Buy After Falling 17% Year to Date?

Y

Betting Against Wall Street: The Inverse ETF Surge No One Is Talking About

Y

Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million

Y

Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position

Y

2 Financial Stocks Poised for a Comeback in 2026

Y

Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction

Y

5 Critical Factors That Could End Gold’s 7-Month Green Streak

Y

My 5 Favorite Dividend Stocks to Buy Right Now

Y

How the Supreme Court tariff ruling tests Fed independence

Y

Downward Price Target Revisions Follow Amdocs Limited (DOX) Earnings

Y

XRP Ledger Launches 'Members-Only' Exchange For Banks, But XRP Can't Break $1.50

Y

Infosys Limited (INFY) Collaborates With Anthropic

Y

Nvidia, Warner Bros., Berkshire Hathaway, Home Depot, and More Stocks to Watch This Week

Y

Accenture plc (ACN) Stock Attractive Again After Pullback Amid New CCO Announcement

Y

$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges

Y

Financial Restrictions To Hurt AppFolio, Inc. (APPF) But Analysts Reaffirm Price Target

Y

Analysts Lower Price Target, But Remain Bullish on Q2 Holdings, Inc. (QTWO)

Y

Earnings and Platform Development Powering The Descartes Systems Group Inc. (DSGX) Bullish Thesis

Y

Here’s Why Wedbush is Bullish on ServiceNow, Inc. (NOW) Again

Y

Here’s What The NBC Deal Means For Sportradar Group AG (SRAD) Stock

Y

GoDaddy Inc. (GDDY) Implements More AI Features Ahead of Earnings

Y

Leveraged ETFs Are Among the Market's Most Aggressive Investment Tools. But Should You Avoid Them Altogether?

Y

International Markets Revenue A Bright Spot For Qualys, Inc. (QLYS)

Y

Arohi Asset Exits a Big Software Bet by Selling 1.7M DoubleVerify (DV) Shares Worth $20.6 Million

Y

Analysts React To Blackbaud, Inc.’s (BLKB) Long Term Growth Guidance

Y

Could Buying XRP Today Set You Up for Life?

Y

Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million

Y

Goldman CEO, NYSE President Attend Trump-Backed World Liberty Crypto Event

Y

Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120%

Y

Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio

Y

Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year

Y

Scaramucci: 'Yes, We're in a Bear Market,' So Get Bitcoin

Y

Vertiv Stock: Buy, Sell, or Hold?

Y

30-year-old beer brand files Chapter 7 bankruptcy to liquidate

Y

Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025

Y

TRUMP and MELANIA Meme Coins Leave Retail Investors With $4.3 Billion Loss

Y